Dose sparing and the lack of a dose-response relationship with an influenza vaccine in adult and elderly patients - a randomized, double-blind clinical trial.

about

Adjuvanted influenza vaccines

P2860

Q57094841-D379E6F0-FA08-41A3-8CEC-47D5F848E78A

P2860

Dose sparing and the lack of a dose-response relationship with an influenza vaccine in adult and elderly patients - a randomized, double-blind clinical trial.

Item

http://www.wikidata.org/entity/Q38853908

description

2017 nî lūn-bûn

@nan

2017年の論文

@ja

2017年論文

@yue

2017年論文

@zh-hant

2017年論文

@zh-hk

2017年論文

@zh-mo

2017年論文

@zh-tw

2017年论文

@wuu

2017年论文

@zh

2017年论文

@zh-cn

name

Dose sparing and the lack of a ...... , double-blind clinical trial.

@en

type

Item

label

Dose sparing and the lack of a ...... , double-blind clinical trial.

@en

prefLabel

Dose sparing and the lack of a ...... , double-blind clinical trial.

@en

P1476

Dose sparing and the lack of a ...... d, double-blind clinical trial

@en

P2093

Adam Erdman

http://www.w3.org/2001/XMLSchema#string

Gergely Balaton

http://www.w3.org/2001/XMLSchema#string

Peter Torzsa

http://www.w3.org/2001/XMLSchema#string

Peter Vajo

http://www.w3.org/2001/XMLSchema#string

Zoltan Vajo

http://www.w3.org/2001/XMLSchema#string

P2860

A reduced-dose seasonal trivalent influenza vaccine is safe and immunogenic in adult and elderly patients in a randomized controlled trial

Influenza: the once and future pandemic

A single-dose influenza A (H5N1) vaccine safe and immunogenic in adult and elderly patients: an approach to pandemic vaccine development

Inactivated whole virus influenza A (H5N1) vaccine

Induction of heterosubtypic cross-protection against influenza by a whole inactivated virus vaccine: the role of viral membrane fusion activity

Safety, Reactogenicity, and Immunogenicity of Inactivated Monovalent Influenza A(H5N1) Virus Vaccine Administered With or Without AS03 Adjuvant.

Superior immunogenicity of inactivated whole virus H5N1 influenza vaccine is primarily controlled by Toll-like receptor signalling.

Safety and immunogenicity of a prepandemic influenza A (H5N1) vaccine in children.

Cross-reactive immunity to clade 2 strains of influenza virus A subtype H5N1 induced in adults and elderly patients by Fluval, a prototype pandemic influenza virus vaccine derived by reverse genetics, formulated with a phosphate adjuvant, and direct

Yearly licensing studies from 1997 to 2007 of the inactivated whole virus seasonal influenza vaccine fluval--a useful approach to pandemic vaccine development even in less well developed countries?

P304

1912-1920

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

P356

10.1111/BCP.13289

http://www.w3.org/2001/XMLSchema#string

P407

English

P433

http://www.w3.org/2001/XMLSchema#string

P478

http://www.w3.org/2001/XMLSchema#string

P50

László Kalabay

P577

2017-04-11T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P698

28378403

http://www.w3.org/2001/XMLSchema#string

P932

5555868

http://www.w3.org/2001/XMLSchema#string

Dose sparing and the lack of a dose-response relationship with an influenza vaccine in adult and elderly patients - a randomized, double-blind clinical trial.

about

P2860

P2860

Dose sparing and the lack of a dose-response relationship with an influenza vaccine in adult and elderly patients - a randomized, double-blind clinical trial.

description

name

type

label

prefLabel

P1433

P1476

P2093

P2860

P304

P31

P356

P407

P433

P478

P50

P577

P698

P932

P356

P1433

P1476

P2093

P2860

P304

P31

P356

P407

P433

P478

P50

P577

P698

P932